The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
Orion to receive an upfront payment of USD 290 million
EVERSANA and Compai Pharma will provide medical and commercial resources to healthcare partners
The investment will enable the company to provide customers with a complete and integrated end-to-end solution
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
HIL has set up the Bti bio-larvicide manufacturing facility at its Rasayani Plant at Maharashtra with the financial assistance of GEF/UNIDO under the project
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
TLANDO was approved by the U.S. Food and Drug Administration (FDA) on March 28, 2022.
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
The drug will be available in 600 hospitals and 105 DTPs
Subscribe To Our Newsletter & Stay Updated
